This compound is a Boc-protected pharmaceutical intermediate featuring a purine core linked to a piperidine ring and a quinazoline group. It is primarily used in the synthesis of more complex active pharmaceutical ingredients.
Escopo do conteúdo: As informações desta página dizem respeito à identificação química e aos contextos de fornecimento industrial, pesquisa e produção. Não constituem alegação terapêutica, aconselhamento médico ou instruções de uso de medicamentos.
Adquirindo ou fornecendo este composto?
Publique seu inventário ou uma solicitação de compra
CAS 668273-75-4
Tert-butyl 4H,5H,6H,7H-thieno[3,2-c]pyridine-5-carboxylate
Boc-protected pharmaceutical intermediate
(S)-tert-Butyl (1-oxo-1-phenylhex-5-yn-2-yl)carbamate
Boc-protected pharmaceutical intermediate
2-chloropyridine-3-sulfonyl Chloride
Pharmaceutical intermediate for sulfonamide synthesis
Alpha-keto-beta-methylvaleric acid, calcium salt
branched-chain keto acid calcium salt
1-methylcyclopropane-1-sulfonamide
pharmaceutical intermediate
2-Chloro-5-methylnicotinic acid
Pharmaceutical intermediate for drug synthesis
LINAGLIPTIN, (S)-
active pharmaceutical ingredient
Linagliptina
active pharmaceutical ingredient
tert-butyl N-[(3R)-1-[7-but-2-ynyl-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-2,6-dioxopurin-8-yl]piperidin-3-yl]carbamate
PQEIZFATTRGTNW-HXUWFJFHSA-N
CC#CCN1C2=C(N=C1N3CCC[C@H](C3)NC(=O)OC(C)(C)C)N(C(=O)N(C2=O)CC4=NC5=CC=CC=C5C(=N4)C)C